Fig. 3.

Survival estimation by Kaplan Meier's method according to definite therapy following neoadjuvant chemotherapy in patients who showed stable disease after neoadjuvant chemotherapy. Five year survival estimation of stable disease in RS and RT group was 76.4% vs. 37.5%, and 10 yr survival estimation was 76.4% vs. 25%. This difference was statistically significant (p=0.0111) by Log rank test.

NACT, neoadjuvant chemotherapy; RS, radical surgery group treated by neoadjuvant chemotherapy plus radical surgery; RT, radiotherapy group treated by neoadjuvant chemotherapy plus radiotherapy.